• OBX share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • Price change

    The price of OBX shares has decreased $1.09 since the market last closed. This is a 5.74% drop.

  • Opened at $18.32.

    The stock opened $0.68 lower than its previous close.

Key terms

About OBX

Obsidian Therapeutics Inc. engages in developing cell and gene therapies, particularly for the treatment of solid tumors and cancer. The company was founded on September 29, 2015 and is headquartered in Malvern, PA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
  • Market cap: $1.18B

    A market capitalization between $300 million and $2 billion places OBX in the small capitalization category.

Key terms

Smart score

Latest OBX news

Aug 18, 2026 6:30am ET Analysts Offer Insights on Healthcare Companies: Obsidian Therapeutics (OBX), Elicio Therapeutics (ELTX) and Aethlon Medical (AEMD) by TipRanks Aug 18, 2026 6:25am ET Obsidian Therapeutics initiated with an Outperform at LifeSci Capital by TipRanks Aug 17, 2026 9:45am ET Galera Therapeutics Inc trading resumes by TipRanks Aug 17, 2026 9:35am ET Galera Therapeutics Inc trading halted, volatility trading pause by TipRanks Aug 17, 2026 3:27am ET Obsidian Therapeutics, Inc. Common Stock trading halted, volatility trading pause by TipRanks Aug 17, 2026 3:26am ET Obsidian Therapeutics, Inc. Common Stock trading resumes by TipRanks Aug 10, 2026 11:20am ET Obsidian Therapeutics, Inc. Common Stock trading resumes by TipRanks Aug 10, 2026 11:10am ET Obsidian Therapeutics, Inc. Common Stock trading halted, volatility trading pause by TipRanks Aug 06, 2026 9:51am ET Zillow downgraded, Global Payments upgraded: Wall Street’s top analyst calls by TipRanks Aug 06, 2026 5:50am ET Obsidian Therapeutics initiated with a Buy at TD Cowen by TipRanks Aug 05, 2026 4:30am ET Obsidian Therapeutics initiated with an Overweight at Piper Sandler by TipRanks Aug 04, 2026 7:30pm ET Obsidian Therapeutics initiated with an Overweight at Piper Sandler by TipRanks

No recent press releases are available for OBX

OBX Financials

1-year income & revenue

  • OBX total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • Net income: $149.05M (1Y), -$1.61M (Q1)

    Net Income increased 886.25% since last year and decreased 101.05% since last quarter.

  • Earnings per share: $302.63 (1Y), -$3.26 (Q1)

    EPS increased 536.09% since last year and decreased 100.8% since last quarter.

Key terms

OBX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

OBX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    OBX's competitors are included in the Health Technology sector and Pharmaceuticals: Major group

  • Market cap: $1.18B

    A market capitalization between $300 million and $2 billion places OBX in the small capitalization category.

Key terms

Latest investing news